vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Riot Platforms, Inc. (RIOT). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($263.6M vs $152.8M, roughly 1.7× Riot Platforms, Inc.). BALCHEM CORP runs the higher net margin — 14.9% vs -452.0%, a 466.8% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (9.8% vs 7.2%). Over the past eight quarters, Riot Platforms, Inc.'s revenue compounded faster (38.8% CAGR vs 4.9%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Riot Platforms, Inc. is a leading U.S.-based enterprise focused on Bitcoin mining, operating multiple large-scale, energy-efficient data centers across North America. It also invests in blockchain infrastructure development and holds Bitcoin as a core long-term reserve asset, centering its business strategy around the digital asset ecosystem.
BCPC vs RIOT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $152.8M |
| Net Profit | $39.2M | $-690.7M |
| Gross Margin | 35.6% | — |
| Operating Margin | 19.8% | -447.9% |
| Net Margin | 14.9% | -452.0% |
| Revenue YoY | 9.8% | 7.2% |
| Net Profit YoY | 16.8% | -606.3% |
| EPS (diluted) | $1.21 | $-1.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $152.8M | ||
| Q3 25 | $267.6M | $180.2M | ||
| Q2 25 | $255.5M | $153.0M | ||
| Q1 25 | $250.5M | $161.4M | ||
| Q4 24 | $240.0M | $142.6M | ||
| Q3 24 | $239.9M | $84.8M | ||
| Q2 24 | $234.1M | $70.0M | ||
| Q1 24 | $239.7M | $79.3M |
| Q4 25 | $39.2M | $-690.7M | ||
| Q3 25 | $40.3M | $104.5M | ||
| Q2 25 | $38.3M | $219.5M | ||
| Q1 25 | $37.1M | $-296.4M | ||
| Q4 24 | $33.6M | $136.4M | ||
| Q3 24 | $33.8M | $-154.4M | ||
| Q2 24 | $32.1M | $-84.4M | ||
| Q1 24 | $29.0M | $211.8M |
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 34.0% | — |
| Q4 25 | 19.8% | -447.9% | ||
| Q3 25 | 20.4% | 44.4% | ||
| Q2 25 | 20.1% | — | ||
| Q1 25 | 20.4% | -144.9% | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 20.0% | -143.3% | ||
| Q2 24 | 19.6% | -167.2% | ||
| Q1 24 | 17.4% | — |
| Q4 25 | 14.9% | -452.0% | ||
| Q3 25 | 15.1% | 58.0% | ||
| Q2 25 | 15.0% | 143.4% | ||
| Q1 25 | 14.8% | -183.6% | ||
| Q4 24 | 14.0% | 95.7% | ||
| Q3 24 | 14.1% | -182.1% | ||
| Q2 24 | 13.7% | -120.6% | ||
| Q1 24 | 12.1% | 267.1% |
| Q4 25 | $1.21 | $-1.89 | ||
| Q3 25 | $1.24 | $0.26 | ||
| Q2 25 | $1.17 | $0.58 | ||
| Q1 25 | $1.13 | $-0.90 | ||
| Q4 24 | $1.03 | $0.39 | ||
| Q3 24 | $1.03 | $-0.54 | ||
| Q2 24 | $0.98 | $-0.32 | ||
| Q1 24 | $0.89 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $233.5M |
| Total DebtLower is stronger | — | $840.8M |
| Stockholders' EquityBook value | $1.3B | $2.9B |
| Total Assets | $1.7B | $3.9B |
| Debt / EquityLower = less leverage | — | 0.29× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $233.5M | ||
| Q3 25 | $65.1M | $330.7M | ||
| Q2 25 | $65.4M | $255.4M | ||
| Q1 25 | $49.9M | $163.7M | ||
| Q4 24 | $49.5M | $277.9M | ||
| Q3 24 | $73.7M | $355.7M | ||
| Q2 24 | $63.7M | $481.2M | ||
| Q1 24 | $60.3M | $688.5M |
| Q4 25 | — | $840.8M | ||
| Q3 25 | — | $5.3M | ||
| Q2 25 | — | $5.3M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | $584.6M | ||
| Q3 24 | — | $5.7M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.3B | $2.9B | ||
| Q3 25 | $1.3B | $3.5B | ||
| Q2 25 | $1.3B | $3.3B | ||
| Q1 25 | $1.2B | $2.9B | ||
| Q4 24 | $1.1B | $3.1B | ||
| Q3 24 | $1.2B | $2.7B | ||
| Q2 24 | $1.1B | $2.6B | ||
| Q1 24 | $1.1B | $2.5B |
| Q4 25 | $1.7B | $3.9B | ||
| Q3 25 | $1.7B | $4.5B | ||
| Q2 25 | $1.7B | $4.3B | ||
| Q1 25 | $1.6B | $3.7B | ||
| Q4 24 | $1.6B | $3.9B | ||
| Q3 24 | $1.6B | $2.9B | ||
| Q2 24 | $1.6B | $2.7B | ||
| Q1 24 | $1.6B | $2.6B |
| Q4 25 | — | 0.29× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $-572.9M |
| Free Cash FlowOCF − Capex | — | $-774.3M |
| FCF MarginFCF / Revenue | — | -506.6% |
| Capex IntensityCapex / Revenue | — | 131.8% |
| Cash ConversionOCF / Net Profit | 1.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-1.4B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $-572.9M | ||
| Q3 25 | $65.6M | $-114.0M | ||
| Q2 25 | $47.3M | $-231.3M | ||
| Q1 25 | $36.5M | $-122.1M | ||
| Q4 24 | $52.3M | $-255.1M | ||
| Q3 24 | $51.3M | $-56.3M | ||
| Q2 24 | $45.0M | $-42.5M | ||
| Q1 24 | $33.4M | $-57.9M |
| Q4 25 | — | $-774.3M | ||
| Q3 25 | — | $-139.7M | ||
| Q2 25 | — | $-291.7M | ||
| Q1 25 | — | $-154.9M | ||
| Q4 24 | — | $-495.4M | ||
| Q3 24 | — | $-127.6M | ||
| Q2 24 | — | $-96.1M | ||
| Q1 24 | — | $-115.2M |
| Q4 25 | — | -506.6% | ||
| Q3 25 | — | -77.5% | ||
| Q2 25 | — | -190.7% | ||
| Q1 25 | — | -96.0% | ||
| Q4 24 | — | -347.5% | ||
| Q3 24 | — | -150.5% | ||
| Q2 24 | — | -137.2% | ||
| Q1 24 | — | -145.2% |
| Q4 25 | — | 131.8% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 39.5% | ||
| Q1 25 | — | 20.4% | ||
| Q4 24 | — | 168.6% | ||
| Q3 24 | — | 84.1% | ||
| Q2 24 | — | 76.5% | ||
| Q1 24 | — | 72.3% |
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | -1.09× | ||
| Q2 25 | 1.23× | -1.05× | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | -1.87× | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | -0.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
RIOT
| Bitcoin Mining Segment | $131.7M | 86% |
| Engineering Segment | $21.1M | 14% |
